| Literature DB >> 29100074 |
Wenhao Yu1, Kevin A Goncalves2, Shuping Li1, Hiroko Kishikawa1, Guangjie Sun3, Hailing Yang2, Nil Vanli4, Yunxia Wu3, Yuxiang Jiang5, Miaofen G Hu5, Roland H Friedel6, Guo-Fu Hu7.
Abstract
Angiogenin (ANG) is a secreted ribonuclease (RNase) with cell-type- and context-specific roles in growth, survival, and regeneration. Although these functions require receptor-mediated endocytosis and appropriate subcellular localization, the identity of the cell surface receptor remains undefined. Here, we show that plexin-B2 (PLXNB2) is the functional receptor for ANG in endothelial, cancer, neuronal, and normal hematopoietic and leukemic stem and progenitor cells. Mechanistically, PLXNB2 mediates intracellular RNA processing that contribute to cell growth, survival, and regenerative capabilities of ANG. Antibodies generated against the ANG-binding site on PLXNB2 restricts ANG activity in vitro and in vivo, resulting in inhibition of established xenograft tumors, ANG-induced neurogenesis and neuroprotection, levels of pro-self-renewal transcripts in hematopoietic and patient-derived leukemic stem and progenitor cells, and reduced progression of leukemia in vivo. PLXNB2 is therefore required for the physiological and pathological functions of ANG and has significant therapeutic potential in solid and hematopoietic cancers and neurodegenerative diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29100074 PMCID: PMC5847377 DOI: 10.1016/j.cell.2017.10.005
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582